Literature DB >> 27984921

Deprescribing: a new goal focused on the patient.

Jorge Enrique Machado-Alba1, Andrés Gaviria-Mendoza1, Manuel Enrique Machado-Duque1, Laura Chica1.   

Abstract

It is estimated that one-fifth of adult patients are treated with polypharmacy (five or more drugs) and the prevalence of this phenomenon in the elderly is even higher, ranging from 30% to 70%, even reaching 90% in residents of residential aged care facilities. Polypharmacy in the elderly increases the risk of adverse reactions, inappropriate prescriptions, drug interactions, number of hospitalizations, costs, and even death. In a recent systematic review, the authors proposed defining deprescribing as 'the process of withdrawal of inappropriate medication supervised by a health care professional with the goal of managing polypharmacy and improving outcomes'.

Entities:  

Keywords:  Deprescriptions; pharmacoepidemiology; pharmacovigilance; polypharmacy

Mesh:

Year:  2016        PMID: 27984921     DOI: 10.1080/14740338.2017.1273347

Source DB:  PubMed          Journal:  Expert Opin Drug Saf        ISSN: 1474-0338            Impact factor:   4.250


  5 in total

1.  Exclusively plant, whole-food diet for polypharmacy due to persistent atrial fibrillation, ischaemic cardiomyopathy, hyperlipidaemia and hypertension in an octogenarian.

Authors:  Andrew B Beauchesne; Alan C Goldhamer; Toshia R Myers
Journal:  BMJ Case Rep       Date:  2018-12-17

2.  Effectiveness of an intervention to optimise the use of mirabegron for overactive bladder: a quasi-experimental study in primary care.

Authors:  Eladio Fernández-Liz; Pere Vivó Tristante; Antonio Aranzana Martínez; Maria Estrella Barceló Colomer; Josep Ossó Rebull; Maria Josep López Dolcet
Journal:  Br J Gen Pract       Date:  2018-11-19       Impact factor: 5.386

Review 3.  Deprescribing of non-antiretroviral therapy in HIV-infected patients.

Authors:  José-Ramón Blanco; Ramón Morillo; Vicente Abril; Ismael Escobar; Enrique Bernal; Carlos Folguera; Fátima Brañas; Mercedes Gimeno; Olatz Ibarra; José-Antonio Iribarren; Alicia Lázaro; Ana Mariño; María-Teresa Martín; Esteban Martinez; Luis Ortega; Julian Olalla; Aguas Robustillo; Matilde Sanchez-Conde; Miguel-Angel Rodriguez; Javier de la Torre; Javier Sanchez-Rubio; Montse Tuset
Journal:  Eur J Clin Pharmacol       Date:  2019-12-21       Impact factor: 2.953

4.  Clinical Outcomes After Discontinuation of Thyroid Hormone Replacement: A Systematic Review and Meta-Analysis.

Authors:  Nydia Burgos; Freddy J K Toloza; Naykky M Singh Ospina; Juan P Brito; Ramzi G Salloum; Leslie C Hassett; Spyridoula Maraka
Journal:  Thyroid       Date:  2020-12-29       Impact factor: 6.568

5.  Deprescribing in primary care in Portugal (DePil17-20): a three-phase observational and experimental study protocol.

Authors:  Pedro Augusto Simões; Luiz Miguel Santiago; José Augusto Simões
Journal:  BMJ Open       Date:  2018-07-17       Impact factor: 2.692

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.